Company / Depreciation & Amortization
C4 Therapeutics, Inc. Depreciation & Amortization History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.0M
FY2025
5-year range
$1.5M / $2.0M
FY2022-FY2025
Trend
+4.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $2M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 3-year CAGR of +9.5%.
Increased from $2M to $2M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +9.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +9.5%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 4.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0M | +4.2% |
| FY2024 | $1.9M | +0.0% |
| FY2023 | $1.9M | +26.0% |
| FY2022 | $1.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026